Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome

R.L. Riha; K. Diefenbach; P. Jennum; W.T. McNicholas

Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome

R.L. Riha, K. Diefenbach, P. Jennum, W.T. McNicholas

19 Citations (Scopus)

Abstract

Though it has long been recognised that there is a hereditary component to the obstructive steep apnoea/hypopnoea syndrome (OSAHS), identifying its genetic basis remains elusive. Hypertension and metabolic syndrome, Like OSAHS, are polygenic disorders, physiologically complex and the product of highly organised, hierarchical systems within the body. Elucidating their genetic basis is difficult when they are considered in isolation but even more difficult if their interrelationships with each other are brought into play. Not least of the problems is the lack of adequate and consistent phenotyping, which has hampered genetic dissection of these diseases; in addition, sleep-disordered breathing has not been factored into most studies dealing with essential hypertension or metabolic syndrome. Genome-wide scans have yielded inconsistent results in all three disorders under discussion and candidate gene studies of possible regulatory molecules require more rigorous replication. One approach would be to use 'intermediate' phenotypes and dense mapping of candidate genes for identifying genotype-phenotype correlations. This review focuses on genetic factors, which may be responsible for the expression of cardiovascular disease and metabolic syndrome in the context of OSAHS. (C) 2007 Elsevier Ltd. All rights reserved
Udgivelsesdato: 2008/2

Original language	English
Journal	Sleep Medicine Reviews
Volume	12
Issue number	1
Pages (from-to)	49-63
Number of pages	14
ISSN	1087-0792
Publication status	Published - 2008

Cite this

@article{9ec6add08bf611de8bc9000ea68e967b,

title = "Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome",

abstract = "Though it has long been recognised that there is a hereditary component to the obstructive steep apnoea/hypopnoea syndrome (OSAHS), identifying its genetic basis remains elusive. Hypertension and metabolic syndrome, Like OSAHS, are polygenic disorders, physiologically complex and the product of highly organised, hierarchical systems within the body. Elucidating their genetic basis is difficult when they are considered in isolation but even more difficult if their interrelationships with each other are brought into play. Not least of the problems is the lack of adequate and consistent phenotyping, which has hampered genetic dissection of these diseases; in addition, sleep-disordered breathing has not been factored into most studies dealing with essential hypertension or metabolic syndrome. Genome-wide scans have yielded inconsistent results in all three disorders under discussion and candidate gene studies of possible regulatory molecules require more rigorous replication. One approach would be to use 'intermediate' phenotypes and dense mapping of candidate genes for identifying genotype-phenotype correlations. This review focuses on genetic factors, which may be responsible for the expression of cardiovascular disease and metabolic syndrome in the context of OSAHS. (C) 2007 Elsevier Ltd. All rights reserved Udgivelsesdato: 2008/2",

author = "R.L. Riha and K. Diefenbach and P. Jennum and W.T. McNicholas",

note = "Times Cited: 1GReviewEnglishRiha, R. LRoyal Infirm, Dept Sleep Med, 51 Little Fracne Crescent, Edinburgh EH16 4SA, Midlothian, ScotlandCited References Count: 133265HMW B SAUNDERS CO LTD32 JAMESTOWN RD, LONDON NW1 7BY, ENGLANDLONDON",

year = "2008",

language = "English",

volume = "12",

pages = "49--63",

journal = "Sleep Medicine Reviews",

issn = "1087-0792",

publisher = "Elsevier Masson",

number = "1",

}

TY - JOUR

T1 - Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome

AU - Riha, R.L.

AU - Diefenbach, K.

AU - Jennum, P.

AU - McNicholas, W.T.

N1 - Times Cited: 1GReviewEnglishRiha, R. LRoyal Infirm, Dept Sleep Med, 51 Little Fracne Crescent, Edinburgh EH16 4SA, Midlothian, ScotlandCited References Count: 133265HMW B SAUNDERS CO LTD32 JAMESTOWN RD, LONDON NW1 7BY, ENGLANDLONDON

PY - 2008

Y1 - 2008

N2 - Though it has long been recognised that there is a hereditary component to the obstructive steep apnoea/hypopnoea syndrome (OSAHS), identifying its genetic basis remains elusive. Hypertension and metabolic syndrome, Like OSAHS, are polygenic disorders, physiologically complex and the product of highly organised, hierarchical systems within the body. Elucidating their genetic basis is difficult when they are considered in isolation but even more difficult if their interrelationships with each other are brought into play. Not least of the problems is the lack of adequate and consistent phenotyping, which has hampered genetic dissection of these diseases; in addition, sleep-disordered breathing has not been factored into most studies dealing with essential hypertension or metabolic syndrome. Genome-wide scans have yielded inconsistent results in all three disorders under discussion and candidate gene studies of possible regulatory molecules require more rigorous replication. One approach would be to use 'intermediate' phenotypes and dense mapping of candidate genes for identifying genotype-phenotype correlations. This review focuses on genetic factors, which may be responsible for the expression of cardiovascular disease and metabolic syndrome in the context of OSAHS. (C) 2007 Elsevier Ltd. All rights reserved Udgivelsesdato: 2008/2

AB - Though it has long been recognised that there is a hereditary component to the obstructive steep apnoea/hypopnoea syndrome (OSAHS), identifying its genetic basis remains elusive. Hypertension and metabolic syndrome, Like OSAHS, are polygenic disorders, physiologically complex and the product of highly organised, hierarchical systems within the body. Elucidating their genetic basis is difficult when they are considered in isolation but even more difficult if their interrelationships with each other are brought into play. Not least of the problems is the lack of adequate and consistent phenotyping, which has hampered genetic dissection of these diseases; in addition, sleep-disordered breathing has not been factored into most studies dealing with essential hypertension or metabolic syndrome. Genome-wide scans have yielded inconsistent results in all three disorders under discussion and candidate gene studies of possible regulatory molecules require more rigorous replication. One approach would be to use 'intermediate' phenotypes and dense mapping of candidate genes for identifying genotype-phenotype correlations. This review focuses on genetic factors, which may be responsible for the expression of cardiovascular disease and metabolic syndrome in the context of OSAHS. (C) 2007 Elsevier Ltd. All rights reserved Udgivelsesdato: 2008/2

M3 - Journal article

SN - 1087-0792

VL - 12

SP - 49

EP - 63

JO - Sleep Medicine Reviews

JF - Sleep Medicine Reviews

IS - 1

ER -